AQR CAPITAL MANAGEMENT LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1167557
Greenwich, CT
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$233,575
-$127,598 QoQ
Shares Held
82,536
-25.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,242,753 across 213 Biotechnology names. MRVI ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in MRVI
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,575 | 82,536 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $361,173 | 111,131 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $176,732 | 61,580 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $144,212 | 59,840 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $34,313 | 15,527 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $279,922 | 51,362 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,654,786 | 319,469 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,534,772 | 773,013 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $24,500,335 | 2,825,875 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $22,951,926 | 3,504,111 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $17,490,030 | 1,749,003 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,046,720 | 969,165 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,101,676 | 1,292,054 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,901,930 | 1,460,652 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $21,899,634 | 857,800 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,851,107 | 593,140 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,348,730 | 151,651 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $215,030 | 5,132 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||